COMMUNIQUÉ DE PRESSE publié le 10/07/2024 à 07:30, il y a 1 année 11 mois Viromed Medical AG seeks special approval for cold plasma device for the prevention of ventilator-associated pneumonia (VAP) Viromed Medical AG seeks special approval for cold plasma device to prevent ventilator-associated pneumonia (VAP). Study aims to revolutionize VAP treatment & reduce mortality Viromed Medical AG Ventilator-associated Pneumonia Cold Plasma Device VAP Prevention Special Approval
BRÈVE publiée le 05/07/2024 à 17:35, il y a 1 année 11 mois Viromed Medical AG Announces Termination of Cooperation with terraplasma medical GmbH Termination Market Expansion Coopération Viromed Medical AG Cold Plasma Devices
BRÈVE publiée le 05/07/2024 à 17:35, il y a 1 année 11 mois Viromed Medical AG annonce la fin de sa coopération avec terraplasma Medical GmbH Coopération L'expansion Du Marché Viromed Medical SA Résiliation Appareils À Plasma Froid
COMMUNIQUÉ DE PRESSE publié le 05/07/2024 à 17:30, il y a 1 année 11 mois EQS-Adhoc: Viromed Medical AG: Viromed Medical GmbH and terraplasma medical GmbH terminate their cooperation with immediate effect Viromed Medical AG terminates cooperation with terraplasma medical GmbH, allowing for expansion of sales potential with own cold plasma devices worldwide Viromed Medical AG Cold Plasma Devices Terraplasma Medical GmbH Cooperation Termination Sales Potential Expansion
BRÈVE publiée le 22/04/2024 à 16:35, il y a 2 années 2 mois Viromed Medical AG Secures Exclusive Agreement with CORIUS Group for Plasma Care® Deployment Healthcare Partnership Viromed Medical AG CORIUS Group Plasma Care
BRÈVE publiée le 22/04/2024 à 16:35, il y a 2 années 2 mois Viromed Medical AG conclut un accord exclusif avec le groupe CORIUS pour le déploiement de Plasma Care® Partenariat Soins De Santé Viromed Medical SA Groupe CORIUS Soins Du Plasma
COMMUNIQUÉ DE PRESSE publié le 22/04/2024 à 16:30, il y a 2 années 2 mois Viromed Medical AG reaches important milestone – agreement with CORIUS Group for exclusive use of Plasma Care® by Viromed with significant growth potential Viromed Medical AG reaches agreement with CORIUS Group for exclusive use of Plasma Care® with significant growth potential, establishing it as benchmark in Germany Viromed Medical AG CORIUS Group Cold Plasma Therapy Plasma Care® Clinical Alliance
BRÈVE publiée le 22/04/2024 à 13:10, il y a 2 années 2 mois Viromed Medical AG Secures Exclusive Rights for Cold Plasma Therapy with CORIUS Group Medical Technology Earnings Growth Viromed Medical AG CORIUS Group Cold Plasma Therapy
BRÈVE publiée le 22/04/2024 à 13:10, il y a 2 années 2 mois Viromed Medical AG obtient les droits exclusifs pour la thérapie par plasma froid avec le groupe CORIUS Technologie Médicale Croissance Des Bénéfices Viromed Medical SA Groupe CORIUS Thérapie Au Plasma Froid
COMMUNIQUÉ DE PRESSE publié le 22/04/2024 à 13:05, il y a 2 années 2 mois EQS-Adhoc: Viromed Medical AG concludes agreement with CORIUS Group for exclusive use of cold plasma therapy with Plasma Care® – Additional earnings contribution of EUR 0.28 to EUR 0.34 per share expected Viromed Medical AG partners with CORIUS Group for exclusive use of cold plasma therapy with Plasma Care®, expecting additional earnings contribution of EUR 0.28 to EUR 0.34 per share from 2025 onwards Earnings Contribution Viromed Medical AG CORIUS Group Cold Plasma Therapy Plasma Care®
Publié le 26/06/2026 à 17:45, il y a 18 heures 33 minutes Descriptif du programme de rachat d'actions
Publié le 27/06/2026 à 01:40, il y a 10 heures 38 minutes Polaris Renewable Energy Announces Results of Director Elections at Annual and Special Meeting
Publié le 27/06/2026 à 00:00, il y a 12 heures 18 minutes Onco-Innovations Initiates Three-Species Hepatocyte and Microsome Metabolism Studies for ONC010
Publié le 26/06/2026 à 23:00, il y a 13 heures 18 minutes Canadian North Resources Inc. Announces Results of 2026 Annual General and Special Shareholders Meeting
Publié le 26/06/2026 à 22:50, il y a 13 heures 28 minutes Banyan Gold Files Technical Report for AurMac Project, Yukon, Canada
Publié le 26/06/2026 à 22:15, il y a 14 heures 3 minutes Revive Therapeutics Announces Proposed Private Placement
Publié le 27/06/2026 à 00:05, il y a 12 heures 13 minutes EAN Congress: Hearing aid use linked to 23% lower dementia risk in people with both epilepsy and hearing loss
Publié le 27/06/2026 à 00:04, il y a 12 heures 14 minutes Persistent and Nagarro sign Business Combination Agreement to form the Persistent - Nagarro Group, a global leader in AI-led digital engineering
Publié le 26/06/2026 à 23:36, il y a 12 heures 42 minutes Persistent and Nagarro sign Business Combination Agreement to form the Persistent – Nagarro Group, a global leader in AI-led digital engineering
Publié le 26/06/2026 à 23:36, il y a 12 heures 42 minutes EQS-Adhoc: Nagarro SE: Nagarro signs business combination agreement with Persistent Systems and supports voluntary public takeover offer to all shareholders at EUR 81 per share
Publié le 26/06/2026 à 23:27, il y a 12 heures 51 minutes EQS-WpÜG: Takeover Offer / Target company: Nagarro SE; Bidder: Galaxy Germany Holding SE